26th Princeton Conference on Cerebrovascular Disease

第26届普林斯顿脑血管疾病会议

• 批准号: 7408397
• 负责人: JAMES C GROTTA
• 金额: $ 10万
• 依托单位: UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-01-01 至 2008-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7408397
• 关键词: Biological Markers; Blood Vessels; Cerebrovascular Disorders; Clinical; Communities; Consensus; Evaluation; Fostering; Genetic; Image; Impaired cognition; Laboratories; Physiological reperfusion; Prevention; Primary Prevention; Proceedings and Conferences; Proceedings, Conference; Progress Review Group; Publishing; Rehabilitation therapy; Reperfusion Therapy; Research; Research Activity; Research Personnel; Scientist; Stroke; Texas; neuroprotection; neurovascular unit; stem cell therapy; symposium

DESCRIPTION (provided by applicant): This application seeks support for the 26th Princeton Conference on Cerebrovascular Disease. The Princeton Conferences have been a landmark every two years since the first one was held in 1954. The 26th Conference will take place March 27-30, 2008 in Houston Texas. The conference will be limited to 150 clinical and laboratory researchers in cerebrovascular disease. A special effort will be made to include promising junior clinical and basic scientists. Our Specific Aims are to: 1. Foster evaluation and completion of the priorities of the Stroke Progress Review Group (SPRG) by focusing the topics of the Princeton Conference on the consensus priorities of the SPRG; 2. Foster a true "translational" focus by including both laboratory and clinical perspectives in each discussion; 3. Stimulate discussion and evaluation of current stroke research activities, and challenge existing assumptions, by presenting the topics in a "controversies" format; 4. Encourage participation by young investigators in the field; and 5. To disseminate the proceedings of the conference to the stroke community. The broad topics to be covered include: Neurovascular Unit, Imaging and Biomarkers, Vascular Cognitive Impairment, Prevention/Genetics, Primary Prevention, ICH, Reperfusion, Neuroprotection, Rehabilitation, and Stem Cell therapy. The aim of this proposal is to use the Princeton Conference to continue the dialogue and research focus of the stroke community on mutually identified priorities. All presentations and discussion will be recorded and published.

描述（由申请人提供）：本申请为第26届普林斯顿脑血管疾病会议寻求支持。自1954年首次举办以来，普林斯顿会议每两年举办一次。第26届会议将于2008年3月27日至30日在德克萨斯州休斯顿举行。会议将限制在150名脑血管疾病的临床和实验室研究人员。将作出特别努力，包括有前途的初级临床和基础科学家。我们的具体目标是：通过将普林斯顿会议的主题集中在卒中进展审查小组（SPRG）的共识优先事项上，促进对SPRG优先事项的评估和完成；2. 通过在每次讨论中包括实验室和临床观点，培养真正的“转化”焦点；3. 刺激讨论和评估当前中风研究活动，并挑战现有的假设，通过提出主题的“争议”格式；4. 鼓励青年研究人员参与该领域；和5。向中风界传播会议记录。将涵盖的广泛主题包括：神经血管单元、成像和生物标志物、血管认知障碍、预防/遗传学、一级预防、脑出血、再灌注、神经保护、康复和干细胞治疗。该提案的目的是利用普林斯顿会议继续对话和研究中风社区共同确定的优先事项。所有的演讲和讨论都将被记录和出版。